Sexual healthcare provider TBD Health has moved into the B2B market by providing digital health companies’ patients access to its at-home sexually transmitted disease tests, diagnostics lab and clinics, the company announced Thursday. TBD…
Continue Reading
What You Should Know:
TBD Health, a sexual healthcare provider revolutionizing the medical landscape through unparalleled digital and in-person clinical care, today announced its entry into the B2B healthcare market by offering fellow digital health companies…
Continue Reading
What You Should Know:
– Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.
– This…
Continue Reading
Behemoth lab test company Quest Diagnostics is partnering with Google’s Fitbit to study how wearable technologies can improve metabolic health. The pilot study, dubbed Wearables for Metabolic Health (WEAR-ME), will combine Fitbit’s behavioral and biometric…
Continue Reading
A three-year collaboration integrates Lunit’s cutting-edge AI into Samsung’s premium X-ray devices, promising revolutionary enhancements in chest screening accuracy and speed. The partnership initially targets the US, Canada, and Europe, focusing on urgent medical…
Continue Reading
What You Should Know:
– Lunit, an innovator in AI-powered cancer diagnostics, and Samsung Electronics (Samsung Healthcare) have announced a groundbreaking three-year supply contract.
– The strategic partnership integrates Lunit’s cutting-edge AI technology into Samsung’s premium…
Continue Reading
Eisai’s collaboration with Oita University heralds a milestone in Alzheimer’s research, presenting an innovative AI model utilizing wearable device data for prediction. The study’s comprehensive approach, encompassing both biological and lifestyle data, results in…
Continue Reading
Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the INVEST conference at the Ritz Carlton in…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing…
Continue Reading
